FWP
NASDAQForward Pharma A/S
Forward Pharma A/S (FWP) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for FWP in the last 30 days. The most recent was published Feb 14, 2023.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Forward Pharma A/S (Amendment)SC 13G/A - Forward Pharma A/S (0001604924) (Subject)
- SECSEC Form EFFECT filed by Forward Pharma A/SEFFECT - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form POS AM filed by Forward Pharma A/SPOS AM - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form S-8 POS filed by Forward Pharma A/SS-8 POS - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form S-8 POS filed by Forward Pharma A/SS-8 POS - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form 15-12G filed by Forward Pharma A/S15-12G - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form 25-NSE filed by Forward Pharma A/S25-NSE - Forward Pharma A/S (0001604924) (Subject)
- 13D/GSEC Form SC 13G filed by Forward Pharma A/SSC 13G - Forward Pharma A/S (0001604924) (Subject)
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
- NEWSS&P 500 Down Over 1%; Crude Oil RisesU.S. stocks traded lower toward the end of trading, with the S&P 500 dropping more than 1% on Monday. The Dow traded down 0.90% to 32,625.78 while the NASDAQ fell 1.71% to 10,522.38. The S&P 500 also fell, dropping, 1.26% to 3,803.96. Also check this: Dow Records Losses For Second Straight Week But Investor Optimism Improves Leading and Lagging Sectors Energy shares rose by 0.4% on Monday. Meanwhile, top gainers in the sector included YPF Sociedad Anónima (NYSE:YPF), up 5%, and Mammoth Energy Services, Inc. (NASDAQ:TUSK), up 4%. In trading on Monday, communication services shares tumbled by 1.5%. Top Headline The NAHB housing market index declined two points to a reading of
- NEWSWhy Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day SessionGainers Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Axcella Health Inc. (NASDAQ:AXLA) shares rose 153% to $0.4105. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2. Camber Energy, Inc. (NYSE:CEI) shares climbed 103% to $0.1257 after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split. Qumu Corporation (NASDAQ:QUMU) gained 98.2% to $0.8722 after Enghouse Systems anno
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers Madrigal Pharmaceuticals (NASDAQ:MDGL) stock rose 232.5% to $212.11 during Monday's regular session. Trading volume for Madrigal Pharmaceuticals's stock is 6.6 million as of 12:30 EST. This is 2108.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.6 billion. Soleno Therapeutics (NASDAQ:SLNO) stock increased by 145.73% to $2.23. Soleno Therapeutics's stock is trading at a volume of 54.5 million shares as of 12:30 EST. This is 84775.2% of its average full-day volume over the last 100 days. The company's market cap stands at $18.1 million. Axcella Health (NASDAQ:AXLA) stock rose 109.74% to $0.34. As of 12:30 EST, this secu
- NEWSDow Drops 75 Points; Qumu Shares Spike HigherU.S. stocks traded lower midway through trading, with the Dow Jones dropping around 75 points on Monday. The Dow traded down 0.23% to 32,845.17 while the NASDAQ fell 1.24% to 10,573.06. The S&P 500 also fell, dropping, 0.62% to 3,828.58. Also check this: Dow Records Losses For Second Straight Week But Investor Optimism Improves Leading and Lagging Sectors Energy shares rose by 0.8% on Monday. Meanwhile, top gainers in the sector included Tidewater Inc. (NYSE:TDW), up 5%, and Mammoth Energy Services, Inc. (NASDAQ:TUSK), up 6%. In trading on Monday, consumer discretionary shares tumbled by 1.5%. Top Headline The NAHB housing market index declined two points to a reading of 31
- NEWSForward Pharma Announced Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketForward Pharma A/S (NASDAQ:FWP) ("we" or "Forward"), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying us that Nasdaq believes that Forward is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. We will not appeal this determination. Therefore, we expect the trading of our American Depositary Shares on The Nasdaq Capital Market to be suspended at the opening of business on December 28, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the "SEC"), which will remove Forward's securities from listing and
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
- PRForward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketCOPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) ("we" or "Forward"), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying us that Nasdaq believes that Forward is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. We will not appeal this determination. Therefore, we expect the trading of our American Depositary Shares on The Nasdaq Capital Market to be suspended at the opening of business on December 28, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the "SEC"),
- NEWSForward Pharma A/S Shares Resume Trade
- NEWSForward Pharma A/S Shares To Resume Trade At 2:30 p.m. ET
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
- NEWSForward Pharma Announces The Decision Of The Enlarged Board Of Appeal Of The European Patent Office In The EP2801355 Petition For Review; Co. Was DeniedForward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company"), today announced that the Enlarged Board of Appeal (the "EBA") of the European Patent Office (the "EPO") has denied Forward's petition for review (the "Petition") of the decision of the Technical Board of Appeal of the EPO that confirmed the revocation of the EP2801355 patent by the EPO Opposition Division in the opposition proceeding ("Opposition Proceeding"). The EBA's rejection of the Petition ends the Opposition Proceeding in favor of the opponents and represents an unsuccessful outcome of the Opposition Proceeding, resulting in no royalties being due to the Company from Biogen based on Biogen's future net sales of Tecfidera
- PRForward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewCOPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company"), today announced that the Enlarged Board of Appeal (the "EBA") of the European Patent Office (the "EPO") has denied Forward's petition for review (the "Petition") of the decision of the Technical Board of Appeal of the EPO that confirmed the revocation of the EP2801355 patent by the EPO Opposition Division in the opposition proceeding ("Opposition Proceeding").The EBA's rejection of the Petition ends the Opposition Proceeding in favor of the opponents and represents an unsuccessful outcome of the Opposition Proceeding, resulting in no royalties being due to the Company from B
- NEWSForward Pharma A/S Shares Halted, News Pending
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
- SECSEC Form 6-K filed by Forward Pharma A/S6-K - Forward Pharma A/S (0001604924) (Filer)
FWP FAQ
7 questionsWhat does Forward Pharma A/S do?
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.What is the latest news on FWP?
Quantisnow has not tracked any new filings, ratings or press releases for FWP in the last 30 days. The most recent wire item was published on February 14, 2023.Where does FWP stock trade?
Forward Pharma A/S (FWP) is listed on NASDAQ.What sector and industry is FWP in?
Forward Pharma A/S operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Forward Pharma A/S go public?
Forward Pharma A/S (FWP) completed its IPO in 2014.What companies are similar to FWP?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare FWP side-by-side with any of them on Quantisnow.How can I track FWP on Quantisnow?
Quantisnow aggregates Forward Pharma A/S's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FWP to receive live email and push alerts on every new disclosure.